Current projects:

NeoPur – H2020-MSCA-IF-2018 “New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling”.

Amount awarded: 184,590.72

Period: 10/2019 – 09/2021

TaPPiNG-EPI – H2020-MSCA-IF-2018 “Targeting Purinergic Pathway in drug-resistant epilepsy using human Neurons and Glia”

Amount awarded: 196,590,72

Period: 04/2019 – 03/2021

H2020-MSCA-IF-2016 “Control of the blood-brain barrier integrity during seizures via the ATP-gated P2X7 receptor”

Amount awarded: €175,866.00

Period: 04/2018 – 03/2020

H2020-MSCA-ITN-2017 “Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases”

Amount awarded: €3,487,463.00 (allocated to PI: €531,349.00)

Period: 09/2017 – 08/2021

H2020-MSCA-IF-2016 “The ATP-P2X7R axis: a target for drug-refractory epilepsy”

Amount awarded: €175,866.00

Period: 01/2018 – 12/2019

Past projects:

• MAPFRE –Reina Sofia Foundation Fellowship “MicroRNAs as new tools in the early detection of mild cognitive impairment and Alzheimer’s disease “

Amount awarded: €16,000.00

Period: 10/2016-09/2018

• EMBO Short term fellowship ASTF No: 458-09 “Imaging proteasome inhibition during seizure induced cell death and epileptogenesis using a transgenic mouse model”

Amount of Award: €3,917.00

Period: 11-12/2009